Program

The scientific program


Please note that this is a preliminary program and may be subject to change.
 

27TH OF JUNE - WEDNESDAY - LOCATED IN HALL A1

Time
18.00-20.00 CONFERENCE OPENING AND WELCOME RECEPTION                                                           
m
 

28TH OF JUNE - THURSDAY - LOCATED IN HALL A1

Time Symposium
n
07.15-08.00           Satellite symposium (room C1-C3)
07.30 Registration opens
n
08.15-08.35 OPENING CEREMONY, Mona Ståhle and Lars Ettarp
08.35-10.00 PLENARY SESSION I - Immunology, chairs Mona Ståhle, Arthur Kavanaugh
Rethinking inflammation: neural circuits in control of immunity
Peder Olofsson
Immunological principles in psoriasis and psoriatic arthritis
Jörg Prinz
Immunological principles in psoriasis and psoriatic arthritis
Christopher Ritchlin
Discussion and Q & A Session with session speakers
n
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-11.10 KEYNOTE LECTURE 1, chairs Alice Gottlieb, Philip Helliwell
Treat to target – but what is the target?
Dr. Peter van de Kerkhof
m
11.10-12.00 Interactive session with two case presentations
CASE 1 - Differential response to treatment (skin vs joints)
Laura Coates
CASE 2 - Concomitant psoriasis and hidradenitis suppurativa
Omid Zargari
n
12.00-13.30 Lunch/Posters/Exhibits
n
12.15-13.15 Satellite symposium (Hall A1)
n
13.30-15.10 PLENARY SESSION 2 - Psoriasis and psoriatic arthritis treatment and care around the world, chairs Ade Adebajo, Steven Loo
Africa, Mahira Hamdy El-Sayed
AsiaPacific, Colin Theng
Middle East, Ori Elkayam
Latin America, Enrique Soriano
15.10-15.30 Oral abstract presentations
Translating WHO resolution into the public: the German program against stigmatization of people with chronic visible skin diseases 
Rachel Sommer
Global Psoriasis Atlas – Work Stream 2 
Nirohshah Suthakharan
n
15.30-16.00 Coffee/Posters/Exhibits
n
16.00-16.40 KEYNOTE LECTURE 2, chairs Matthias Augistin, Christopher Ritchlin
The Global Psoriasis Atlas: a tool to address unmet needs in psoriasis
Christopher Griffiths
17.00-18.00 Satellite Symposium (Hall A1)
m
 

29TH OF JUNE - FRIDAY - LOCATED IN HALL A1

Time Symposium
07.30-08.15          Satellite symposium (room C1-C3)
m
08.30-09.40 PLENARY SESSION 3 - Diagnostics – biomarkers and clinical indicators, chairs Lone Skov, Laura Coates
Biomarkers in psoriasis and psoriatic arthritis
Vinod Chandran
Early detection of psoriatic arthritis in psoriasis patients
Joseph Merola
Discussion with Q & A session
09.40-10.00 Oral abstract presentations
Association between inflammasome-related polymorphisms and clinical phenotypes of Psoriatic arthritis Kristina Juneblad
Environmental triggers of an HLA-C*06:02-restricted autoimmune response in psoriasis
Secil Vural 
m
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-12.00 PLENARY SESSION 4 - Challenges in disease management, chairs Alan Menter, Dafna Gladman
Addressing well-being: The overlooked element in psoriatic diseases
Elaine Husni
Management of psoriasis/psoriatic arthritis before, during and after pregnancy
Arthur Kavanaug
Management of psoriasis in the pediatric population
Marieke Seyger
Presentation of a challenging paediatric psoriasis case
Josefin Lysell
Presentation of a challenging case – psoriasis/psoriatic arthritis during pregnancy: Pregnant female with severe flare of skin and joints – treatment options
Abby Van Voorhees
12.00-13.30 Lunch/Posters/Exhibits
m m
12.15-13.15 Satellite symposium (Hall A1)
m m
13.30-15.30 PLENARY SESSION 5 - Treatment guidelines and outcomes measures, chairs Jo Lambert, Christopher Ritchlin
Current treatment guidelines for psoriasis and psoriatic arthritis
Laura Coates
Outcomes measures in psoriasis and psoriatic arthritis – a comprehensive review
Kristina Callis Duffin
OPEN MIKE SESSION - The ideal treatment – what is it and is it possible to attain? 
Moderator: Kilian Eyerich
Panelists: Ulrich Mrowietz, Philip Helliwell, Silvia Fernandez Barrio, Ingvar August Ingvarsson
 
15.30-16.00 Coffee/Posters/Exhibits
m
16.00-16.40 KEYNOTE LECTURE 3 -
The virtual doctor: Working in a virtual treatment environment
Luis Mazzuoccolo
 
17.00-18.00 Satellite Symposium (Hall A1)
M
 

30TH OF JUNE - SATURDAY - LOCATED IN HALL A1

Time Symposium
m
07.30-08.15           Satellite symposium (room C1-C3)
                    
08.30–09.20 PLENARY SESSION 6 - Treatments for psoriasis and psoriatic arthritis, chairs Abrar Qureshi, Arthur Kavanaugh
 Management of low-to-moderate psoriasis severity
Jo Lambert
New to market - an overview
Lars Iversen
Panel discussion with Q & A session
09.20-10.00 Interactive session with two case presentations - focus on management of  comobidities
M
CASE 1: Comorbidities and treatment sin patients with inverse psoriasis
Mia Schneeweiss
CASE 2: Concomitant neoplasm
Paolo Gisondi
10.00-10.30 Coffee/Posters/Exhibits
m
10.30-11.10 KEYNOTE LECTURE 4, chairs Mona Ståhle, Philip Mease
15 years of biologic treatment of psoriasis and psoriatic arthritis - long-term afficacy and safety (Split Keynote):
Psoriasis and biologics
Alice Gottlieb
Psoriatic arthritis and biologics
Dafna Gladman
11.10-12.00 PLENARY SESSION 7 - Biosimilars
How original is the original?
Arnon Cohen
Recommendations for usage of biosimilars
Lone Skov
Panel discussion with Q & A session
 
12.00-13.30 Lunch/Posters/Exhibits
12.15-13.15 Satellite symposium (Hall A1)
13.30-15.00 PLENARY SESSION 8 - Comorbidities associated with psoriasis and psoriatic arthritis, chairs Lars Iversen, Vinod Chandran
Overview of comorbidity profiles and screening recommendations
Luigi Naldi
The gut-joint axis in psoriatic arthritis
Francesco Ciccia
Psoriasis, psoriatic arthritis and cardiovascular disease
Nehal Mehta
Psoriasis, psoriatic arthritis and the brain
Jashin Wu
Discussion
15.00-15.30 Coffee/Posters/Exhibits
15.30-16.10 KEYNOTE LECTURE 5, chairs Kristina Callis Duffin, Elaine Husni
Is an integrated psoriasis care possible – or just an utopian patient dream? 
Abrar Qureshi
16.10-16.30 CLOSING DISCUSSION - The Global Psoriasis Coalition and the way forward
Mario Ottiglio, Mona Ståhle, Lars Ettarp and Fiona Adshead
16.30-16.45 Closing of scientific program
Mona Ståhle

The International Federation of Psoriasis Associations is a non-profit organization representing over 125 million people living with psoriasis or psoriatic arthritis worldwide.

IFPA Secretariat
Gustavslundsvägen 143
167 51 Bromma, SWEDEN